Analyzing the Latest 13F Filing for Strategic Insights

Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2025, providing insights into his investment moves during this period. Robert Bruce (Trades, Portfolio) is the founder of Bruce & Co, the investment firm that serves as the advisor to the Bruce Fund (BRUFX). The Bruce Fund is run by Robert Bruce (Trades, Portfolio) and his son, Robert Jeffrey Bruce. The Fund focuses primarily on common stock investments, though it also invests in high-yield and distressed debt. It may invest in some long-term U.S. government securities if the managers cannot find attractive opportunities elsewhere. The Fund invests mostly in small- and mid-cap stocks, with the occasional large-cap, as well as convertible and distressed bonds. The Bruces tend to hold their stocks for the long-term, generally preferring the securities of distressed companies that are trading at a significant discount but which they believe can make a turnaround.

Warning! GuruFocus has detected 4 Warning Signs with UHAL.B.Robert Bruce's Strategic Moves: CMS Energy Corp Sees a -1.29% Portfolio Impact

Summary of New Buy

Robert Bruce (Trades, Portfolio) added a total of 2 stocks, among them:

The most significant addition was The Chemours Co (NYSE:CC), with 200,000 shares, accounting for 0.87% of the portfolio and a total value of $2.706 million. The second largest addition to the portfolio was Venture Global Inc (NYSE:VG), consisting of 100,000 shares, representing approximately 0.33% of the portfolio, with a total value of $1.03 million.

Key Position Increases

Robert Bruce (Trades, Portfolio) also increased stakes in a total of 2 stocks, among them:

The most notable increase was AerCap Holdings NV (NYSE:AER), with an additional 33,500 shares, bringing the total to 183,500 shares. This adjustment represents a significant 22.33% increase in share count, a 1.1% impact on the current portfolio, with a total value of $18,748,200. The second largest increase was Fate Therapeutics Inc (NASDAQ:FATE), with an additional 200,000 shares, bringing the total to 550,000. This adjustment represents a significant 57.14% increase in share count, with a total value of $434,500.

Key Position Reduces

Robert Bruce (Trades, Portfolio) also reduced positions in 9 stocks. The most significant changes include:

Reduced CMS Energy Corp (NYSE:CMS) by 60,000 shares, resulting in a -20.98% decrease in shares and a -1.29% impact on the portfolio. The stock traded at an average price of $69.84 during the quarter and has returned 0.87% over the past 3 months and 4.96% year-to-date. Reduced AT&T Inc (NYSE:T) by 100,000 shares, resulting in a -12.94% reduction in shares and a -0.73% impact on the portfolio. The stock traded at an average price of $25.15 during the quarter and has returned 3.38% over the past 3 months and 18.95% year-to-date.

Story Continues

Portfolio Overview

At the first quarter of 2025, Robert Bruce (Trades, Portfolio)'s portfolio included 41 stocks, with top holdings including 8.61% in U-Haul Holding Co (NYSE:UHAL.B), 8.6% in AbbVie Inc (NYSE:ABBV), 8.37% in Allstate Corp (NYSE:ALL), 7.19% in NextEra Energy Inc (NYSE:NEE), and 6.91% in Duke Energy Corp (NYSE:DUK).Robert Bruce's Strategic Moves: CMS Energy Corp Sees a -1.29% Portfolio Impact

The holdings are mainly concentrated in 9 of all the 11 industries: Utilities, Healthcare, Industrials, Financial Services, Communication Services, Consumer Defensive, Technology, Basic Materials, and Energy.Robert Bruce's Strategic Moves: CMS Energy Corp Sees a -1.29% Portfolio Impact

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.

View Comments